• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
4 Vision Marketing Arthritis Out Licensing Apr2009
 

4 Vision Marketing Arthritis Out Licensing Apr2009

on

  • 665 views

overview of current Arthitis products available for out-licensing

overview of current Arthitis products available for out-licensing

Statistics

Views

Total Views
665
Views on SlideShare
663
Embed Views
2

Actions

Likes
0
Downloads
5
Comments
0

1 Embed 2

http://www.linkedin.com 2

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    4 Vision Marketing Arthritis Out Licensing Apr2009 4 Vision Marketing Arthritis Out Licensing Apr2009 Presentation Transcript

    • Out-licensing of Arthritis compounds
      • Licensing options Arthritis
      • Stable protein compound for immune disorders, most advanced programmes are in Rheumatoid Arthritis & Type 1 Diabetes . Status: preclinical phase finalised.
      • RA antibody currently in preclinical development, with significant advantages over anti-TNF antibodies in arthritis. Product only depletes the activated T cells leaving the other T cells intact to fight off infections etc. 
      • We look for potential partners for these products and for new product opportunities.
      • Activities 4Vision Marketing
      • Marketing, sales & business development towards the European biotech & pharma
      • In- and outlicensing of products and technologies
      • Consulting services
      • Find outsoucing partners for the European innovative biotech & pharma companies
      • Architects of outsourcing
      • Out-licensing
      • Guiding principles for 4Vision involvement:
      • We work for the company that is out-licensing; they pay our bill.
      • We do not require advance payment if the licensing proposal is well worked out
      • (we can offer to work out the proposal for an hourly rate)
      • Our reward is a percentage of the total deal with the customer (down payment, milestones, royalties)
      • How do we work in outlicensing of products and technology?
      • Use our European database of companies
      • Regular contact with the European biotech community
      • Select most likely candidates for matching
      • Use a focussed one-on-one approach
      • European network of professionals
      • 4Vision Marketing
      • Founded 2003 by Jan W. Zuidema
      • 20+ years of experience in B2B marketing & sales of high tech products & services
      • 12+ years of experience in biotech & pharma
      • embedded in a network of biotech & pharma professionals
      • Located in the Netherlands
      • Please contact us!
      • 4Vision Marketing
      • Zuidbrink 24
      • 9431 AR Westerbork
      • The Netherlands
      • Tel: +31 593 370006
      • Mail: [email_address]
      • url: www.4vmarketing.com